Starpharma need to choose the right global partner and it could .... IMO if they have undertaken a production run, which Starpharma already claim to have done in previous announcements, then why hide who this was with - sign the deal already ? ... and make it a large global pharma deal instead of bits and pieces in each country with different groups because we can see how that is working out for Vivagel (NOT)
As I have mentioned previously, based on past performance I would also prefer the 'distribution pharma company' to handle all the regulatory body submissions, especially in the USA - just sayin'
GLTAH
P.S. ... I say again bring on the overdue DEP Docetaxel phase 2 mono results !
SPL Price at posting:
$1.41 Sentiment: Hold Disclosure: Held
